There were 2,236 press releases posted in the last 24 hours and 440,047 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
GeneTx and Ultragenyx Announce Investigational New Drug (IND) Application Active for GTX-102 in Patients with Angelman Syndrome

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image